In Vitro Diagnostic Test Distribution in Ukraine with GoodMed

Birmingham Biotech is currently distributing BHM® COVID-19 Antigen Rapid Tests to Ukraine in partnership with GoodMed, who owns and operates laboratories in Ukraine and distributes IVD tests locally.

GoodMed and Birmingham Biotech will partner to fulfil local needs for in vitro diagnostic testing and medical equipment distribution based on a signed distribution and partnership agreement.

Previous
Previous

Performance Evaluation Study for the Detection of SARS-CoV-2 in Asymptomatic Patients by University of Birmingham Shows 99.95% Accuracy

Next
Next

Validation Results for BHM® COVID-19 Antigen Rapid Test Shows up to 98.34% Accuracy in Lab Testing